| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1590/S0004-27302011000200002 |
| P8608 | Fatcat ID | release_eagpnutwkrebzm6asinhsc7nte |
| P698 | PubMed publication ID | 21584427 |
| P2093 | author name string | Caroline K Kramer | |
| Luís Henrique Canani | |||
| Daisy Crispim | |||
| Fabiana Borba Valiatti | |||
| Bruna Borba Valiatti | |||
| Camila Benfica | |||
| P2860 | cites work | Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis | Q24681191 |
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Diabetic retinopathy | Q28194521 | ||
| Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium | Q28512027 | ||
| The biology of vascular endothelial growth factor | Q29615946 | ||
| Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema | Q30784200 | ||
| Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies | Q30978576 | ||
| Management of diabetic retinopathy: a systematic review | Q33294803 | ||
| Vascular endothelial growth factor: basic science and clinical progress | Q34549887 | ||
| Vascular permeability, vascular hyperpermeability and angiogenesis | Q34753662 | ||
| Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales | Q35226427 | ||
| Scatter factor induces blood vessel formation in vivo | Q36141804 | ||
| Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. | Q36796674 | ||
| Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy | Q37135388 | ||
| Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence | Q39233637 | ||
| The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 | ||
| VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression | Q40497297 | ||
| Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal | Q40848490 | ||
| The pathophysiology of angiogenesis | Q41094491 | ||
| Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients | Q43268630 | ||
| UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. | Q43554872 | ||
| Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin | Q44083468 | ||
| Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes | Q44779289 | ||
| Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy | Q46532695 | ||
| Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes | Q46553198 | ||
| Diabetic retinopathy risk factors | Q46573010 | ||
| Single nucleotide polymorphisms of vascular endothelial growth factor gene intron 2 are markers for early progression of diabetic retinopathy in Japanese with type 1 diabetes. | Q51784130 | ||
| VEGF Polymorphisms Are Associated with Severity of Diabetic Retinopathy | Q57010448 | ||
| Association of VEGF Gene Polymorphisms with Diabetic Retinopathy in a South Indian Cohort | Q57254310 | ||
| An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy | Q57971999 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | Portuguese | Q5146 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 106-113 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Arquivos Brasileiros de Endocrinologia e Metabologia | Q15751181 |
| P1476 | title | [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy]. | |
| P478 | volume | 55 |
| Q36441396 | Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes. |
| Q52632539 | Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review. |
| Q34160549 | Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats |
| Q37029343 | High Glucose and Glucose Deprivation Modulate Müller Cell Viability and VEGF Secretion |
| Q55186667 | Intranasal delivery of VEGF enhances compensatory lung growth in mice. |
| Q51639014 | MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy. |
| Q38248725 | Nitric oxide in the normal kidney and in patients with diabetic nephropathy |
| Q38187444 | Nitric oxide system and diabetic nephropathy |
| Q51141075 | Role of microRNA-29a in the development of diabetic retinopathy by targeting AGT gene in a rat model. |
Search more.